pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 13·1 min read
save

Biopharma launches nominations for 2025 pay report and highlights Parabilis record IPO

Jun 13, 2026·read at Endpoints ↗DealNeutral

Endpoints Weekly announced the start of nominations for its eighth annual Women in Biopharma report, aiming to feature 20 distinguished women across science, leadership, and entrepreneurship.

The call invites scientists, executives, founders and other enterprising women to share their experiences and contributions to the biopharma sector.

In the same briefing, the newsletter noted that Parabilis achieved a record-setting initial public offering, marking a significant milestone for the company and the industry.

The combined announcements underscore ongoing efforts to highlight diversity in biopharma while tracking notable financial events.

source

This writeup was produced by pharmadog from original reporting by Endpoints. The original article may no longer be reachable at its published URL.

Original headline: “Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more”

read at Endpoints ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoExclusive: Astellas partners with Boston ‘miniproteins’ startupEndpoints
  • 2h agoRapport says drug it licensed from J&J clears Phase 2 bipolar mania studyEndpoints
  • 18h agoFormer MIT professor David Sabatini awarded $6M in defamation caseEndpoints
  • 18h agoAntheia gets $80M conditional DOD loan to onshore to the USEndpoints
  • 20h ago#ESMO26 regular abstracts featuring Zai Lab, GSK, Merck and moreEndpoints